- Home
- CELC vs SHYF Comparison
CELC vs SHYF Comparison
Compare CELC & SHYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- SHYF
- Stock Information
- Founded
- CELC 2011
- SHYF 1975
- Country
- CELC United States
- SHYF United States
- Employees
- CELC N/A
- SHYF N/A
- Industry
- CELC Medical Specialities
- SHYF Auto Manufacturing
- Sector
- CELC Health Care
- SHYF Consumer Discretionary
- Exchange
- CELC Nasdaq
- SHYF Nasdaq
- Market Cap
- CELC 327.3M
- SHYF 428.3M
- IPO Year
- CELC 2017
- SHYF N/A
- Fundamental
- Price
- CELC $10.53
- SHYF $9.12
- Analyst Decision
- CELC Strong Buy
- SHYF Strong Buy
- Analyst Count
- CELC 6
- SHYF 2
- Target Price
- CELC $30.17
- SHYF $15.50
- AVG Volume (30 Days)
- CELC 195.9K
- SHYF 289.5K
- Earning Date
- CELC 05-14-2025
- SHYF 04-24-2025
- Dividend Yield
- CELC N/A
- SHYF 2.17%
- EPS Growth
- CELC N/A
- SHYF 744.40
- EPS
- CELC N/A
- SHYF 0.01
- Revenue
- CELC N/A
- SHYF $792,886,000.00
- Revenue This Year
- CELC N/A
- SHYF $15.03
- Revenue Next Year
- CELC N/A
- SHYF $8.68
- P/E Ratio
- CELC N/A
- SHYF $727.54
- Revenue Growth
- CELC N/A
- SHYF N/A
- 52 Week Low
- CELC $7.58
- SHYF $6.82
- 52 Week High
- CELC $19.77
- SHYF $17.56
- Technical
- Relative Strength Index (RSI)
- CELC 51.41
- SHYF 56.84
- Support Level
- CELC $9.64
- SHYF $8.66
- Resistance Level
- CELC $11.66
- SHYF $9.30
- Average True Range (ATR)
- CELC 0.66
- SHYF 0.55
- MACD
- CELC -0.04
- SHYF 0.16
- Stochastic Oscillator
- CELC 44.06
- SHYF 89.15
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About SHYF The Shyft Group Inc.
The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.